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Background: Aging is not just a risk factor of stroke, but it has also been associated with poor recovery. It is known
that stroke-induced neurogenesis is reduced but maintained in the aged brain. However, there is no consensus on
how neurogenesis is affected after stroke in aged animals. Our objective is to determine the role of aging on the
process of neurogenesis after stroke.
Methods: We have studied neurogenesis by analyzing proliferation, migration, and formation of new neurons, as
well as inflammatory parameters, in a model of cerebral ischemia induced by permanent occlusion of the middle
cerebral artery in young- (2 to 3 months) and middle-aged mice (13 to 14 months).
Results: Aging increased both microglial proliferation, as shown by a higher number of BrdU+ cells and BrdU/
Iba1+ cells in the ischemic boundary and neutrophil infiltration. Interestingly, aging increased the number of M1
monocytes and N1 neutrophils, consistent with pro-inflammatory phenotypes when compared with the alternative M2
and N2 phenotypes. Aging also inhibited (subventricular zone) SVZ cell proliferation by decreasing both the number
of astrocyte-like type-B (prominin-1+/epidermal growth factor receptor (EGFR)+/nestin+/glial fibrillary acidic protein
(GFAP)+ cells) and type-C cells (prominin-1+/EGFR+/nestin−/Mash1+ cells), and not affecting apoptosis, 1 day after
stroke. Aging also inhibited migration of neuroblasts (DCX+ cells), as indicated by an accumulation of neuroblasts
at migratory zones 14 days after injury; consistently, aged mice presented a smaller number of differentiated
interneurons (NeuN+/BrdU+ and GAD67+ cells) in the peri-infarct cortical area 14 days after stroke.
Conclusions: Our data confirm that stroke-induced neurogenesis is maintained but reduced in aged animals.
Importantly, we now demonstrate that aging not only inhibits proliferation of specific SVZ cell subtypes but also
blocks migration of neuroblasts to the damaged area and decreases the number of new interneurons in the
cortical peri-infarct area. Thus, our results highlight the importance of using aged animals for translation to clinical
studies.
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Stroke remains a colossal therapeutic challenge. Being a
leading cause of death and disability worldwide, the only
treatment available in the acute phase of stroke is thromb-
olysis with tissue plasminogen activator (tPA), a drug that
can be administered to a low percentage of patients due to
its narrow therapeutic window (<4.5 h) and safety con-
cerns. In contrast, in the chronic phase, a broader window
might exist for therapeutic interventions that may serve to
promote repair in late stages and to decrease stroke-
associated disability.
Importantly, stroke affects predominantly the elderly, a
population segment that is dramatically rising due to the
increased life expectancy. But old age is not just a risk
factor of stroke: it has also been associated with an en-
hanced susceptibility to stroke and poor recovery from
brain injury (for review, see [1]). In spite of this, most re-
search is developed in young animals, whereas the effect
of aging remains understudied.
Several reasons may account for the increased suscep-
tibility of the aged brain. For instance, aged brain is
characterized by the existence of an activated basal state
of low-grade chronic inflammation which has been
called ‘inflamm-aging’ [2] and which might lead not only
to more severe and persistent behavioral and cognitive
deficits after stroke but also to an impaired recovery
during the chronic phase of stroke [3-5]. In addition,
aging is also associated with microgliosis, a cellular re-
sponse that may have both beneficial and deleterious
consequences for neurogenesis (for review, see [6]). In
this line, it is widely accepted that adult neurogenesis is
decreased but maintained in the aging brain after injury
(for review, see [1]). However, how neurogenesis is af-
fected by aging, a situation in which infarct size, micro-
glial, and inflammatory response are likely to be affected,
is still unclear and controversial.
Therefore, the objective of this study is to explore fur-
ther the role of aging on the process of neurogenesis after
stroke by analyzing proliferation, migration, and formation
of new neurons in young- (2 to 3 months) and middle-
aged (13 to 14 months) mice exposed to focal cerebral is-
chemia by a permanent middle cerebral artery occlusion
(MCAO).Methods
Animals
Adult male C57BL/10 J young (2 to 3 months) and aged
(13 to 14 months) mice were used (Jackson Labs, Bar
Harbor, ME, USA). All experimental protocols adhered
to the guidelines of the Animal Welfare Committee of
the Universidad Complutense (EU directives 86/609/
CEE and 2003/65/CE). Mice were housed under stand-
ard conditions of temperature and humidity and a 12-h-light/dark cycle (lights on at 08:00) with free access to
food and water.
Experimental groups
All groups were performed and quantified in a random-
ized fashion (coin toss) by investigators blinded to each
specific treatment. Mice were subjected to a distal per-
manent middle cerebral artery occlusion (MCAO) by
ligation. Sham-operated animals, considered as control
group, were subjected to anesthesia and the surgical pro-
cedure, but the occlusion of the artery was omitted.
5-Bromo-2′-deoxyuridine (BrdU, 50 mg/kg) was injected
i.p. once daily from days 5 to 6 after ischemia. Cell prolifer-
ation was quantified 7 and 14 days after ischemia by im-
munohistochemical studies.
Induction of permanent focal ischemia
Surgery leading to focal cerebral ischemia was conducted
under anesthesia with isoflurane in a mix of O2 and N2O
(0.2/0.8 L/min). During surgery, body temperature was
maintained at 37.0°C ± 0.5°C using a servo-controlled
rectal probe-heating pad. The surgical procedure was a
variant of that described by Chen et al. [7]. A small crani-
otomy was made over the trunk of the left middle cerebral
artery and above the rhinal fissure. The permanent middle
cerebral artery (MCA) occlusion (MCAO) was done by
ligature of the trunk (proximal occlusion) just before its
bifurcation between the frontal and parietal branches with
a 9-0 suture. Because we demonstrated that cell prolifera-
tion is dependent on infarct size after stroke [8] and be-
cause there is also contradictory information in the
literature on the effect of age on infarct size, we included
an additional group in which MCAO was performed on a
posterior branch of the MCA (distal occlusion) to obtain
smaller infarct volumes. The method used is exactly the
same for both, the only difference being the site in which
the occlusion is performed. Complete interruption of
blood flow was confirmed under an operating microscope.
Physiological parameters (rectal temperature, mean ar-
terial pressure, pO2, pCO2, pH) were not significantly
different between all studied groups (data not shown).
No spontaneous mortality was found after MCAO with
this model, and this was unaffected by the different ex-
perimental groups.
Infarct size determination
For infarct size determination 48 hours after MCAO,
magnetic resonance examination was performed using a
BIOSPEC BMT 47/40 (Bruker, Ettlingen, Germany). In-
farct volume was calculated using ImageJ 1.44l (NIH,
Bethesda, MD, USA) from the T2-weighted images.
In addition, infarct volume was determined by Nissl
staining at later times: animals subjected to MCAO were
killed 7 and 14 days after surgery and subjected to
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phate buffer (pH 7.4); brains were then frozen, serially
sectioned at 40 μm, and stained with conventional histo-
logical Nissl (0.1% cresyl violet) staining. With the obser-
ver masked to the experimental conditions, the areas of
the infarcted tissue (InfArea), the whole ipsilesional hemi-
sphere (IpsArea), and the whole contralesional hemi-
sphere (ContrArea) were delineated for each slice. Then,
infarct volume, expressed as % of the hemisphere that is
infarcted (%IH), was calculated as previously described [9]
using the formula: %IH = InfVol/ContrVol*100 where
InfVol (Infarcted Tissue Volume) = ∑InfAreai/SwellingIn-
dexi, ContrVol (Contralesional Hemisphere Volume) =
∑ContrAreai, and SwellingIndexi = IpsAreai/ContrAreai.
Immunofluorescence studies
Animals (n = 6 to 7 for each group) were killed 7 or 14
days after MCAO by pentobarbital overdose followed by
transcardiac perfusion through the left ventricle with 0.1
M phosphate buffer as a vascular rinse followed by a fix-
ing solution containing 4% p-formaldehyde in 0.1 M
phosphate buffer (pH 7.4). Brains were removed, post-
fixed overnight, and placed in 30% sucrose for 48 h. Cor-
onal series sections (40 μm) were cut on a freezing
microtome (Leica SM2000R, Leica Microsystems GmbH,
Wetzlar, Germany) and stored in cryoprotective solution.
Double-label immunofluorescence was performed on
free-floating sections and incubated overnight at 4°C with
the primary antibodies rat anti-BrdU (1:100; ABD Serotec,
Bio-Rad Lab. Inc., Hercules, CA, USA), rabbit anti-Iba1
(1:500; Wako, Osaka, Japan), goat anti-doublecortin
(DCX; 1:500; Santa Cruz Biotech, Heidelberg, Germany),
mouse anti-NeuN (1:200 MAB 377; Millipore, Billerica,
MA, USA), and rabbit anti-glutamic acid decarboxylase
67 (GAD67; 1:200; Abcam pic). After incubating with the
primary antibody, sections were washed and incubated
with the appropriate fluorescent secondary antibody: goat
anti-rabbit biotin and horse anti-goat biotin (Vector Lab,
Peterborough, UK) in combination with Alexa488 strepta-
vidin (Molecular Probes, Life Tech, Madrid, Spain),
Alexa647 (Invitrogen SA, Barcelona, Spain), and donkey
Cy3 anti-rat/anti-mouse (Jackson Immunoresearch,
Suffolk, UK). Controls performed in parallel without
primary antibodies showed very low levels of nonspe-
cific staining.
For the immunofluorescence study of apoptosis by deter-
mination of caspase-3 positive cells, sections were pre-
treated using heat-mediated antigen retrieval with sodium
citrate buffer (10 mM, pH6, in 0.05% Tween 20) for 40
minutes and 100°C and then incubated overnight with anti-
body caspase-3 (1:15, Enzo). Next day, sections were
washed and incubated with goat anti-rabbit biotin second-
ary antibodies (Vector Laboratories, Peterborough, UK) in
combination with Alexa488 streptavidin (Molecular Probes;Life Technologies, Madrid, Spain). Confocal images
were taken from three correlative sections. Stacks at
20× of the infarct zone were obtained and analyzed
with the ImageJ 1.44l software.
Cell quantification and optical density on confocal images
For the study of neuroblasts (DCX+ cells), immunofluor-
escence images were obtained in a blinded manner from
four correlative slices of each brain. Stacks at 20× of the
subventricular zone (SVZ; Z1) were obtained. In
addition, two adjacent images (Z2 and Z3) along the cor-
pus callosum were also obtained. With the ImageJ
v.1.44l software (NIH, Bethesda, MD, USA), each image
was converted into a binary image and the integrated
density (IntDen) was calculated. The IntDen is a calculus
of the mean stained area times the intensity of stain in
each pixel in the area and indicates the total amount of
stained material in that area.
For neuronal differentiation (BrdU+/NeuN+ cells), im-
munofluorescence images were taken from five correla-
tive sections beginning in 1.70 mm from the bregma
(until 0.02 mm). The images were taken at 40× and
spaced 400 μm from each other. The entire top of the
cortex was traced and 800 μm below the stroke, using as
boundaries of the corpus callosum and the end of the
cortex, by analyzing a total of about 16 to 18 images per
hemisphere and section.
The number of BrdU+ and BrdU+/Iba+ cells was quan-
tified on digitalized confocal images captured from six
serial 40-μm sections spaced 0.32 mm apart (two fields
of view per section; Zeiss LSM 710) in ipsi- and contra-
lateral cortices. Three-dimensional colocalization of pro-
tein markers was validated using confocal z-stacks.
Unbiased stereology
The total volume of the dorsolateral striatal extension of
the subventricular zone (SVZ) was estimated by the ap-
plication of the Cavalieri’s principle on seven serial sec-
tions per brain (40-μm thickness, 0.32 mm apart)
(bregma 1.70 mm to -0.54 mm). The morphological cri-
teria used for the consistent delineation of the SVZ are
described elsewhere [10]. Stereological estimation of the
total number of BrdU+ cells in the dorsolateral extension
of the SVZ was performed using the optical fractionator
method [11]. The specific parameters used for stereolog-
ical sampling and quantification of BrdU+ cells are de-
scribed in [7].
Brain dissociation and cell suspensions analysis by flow
cytometry
Brain cell suspensions were prepared as described in
[12,13]. Briefly, 1 and 2 days after MCAO, mice brain
was rapidly removed. Cortex and subventricular zones
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ice-cold PBS.
In the case of SVZ, cells were dissociated in a single
cell suspension using an enzymatic dissociation kit
(neural tissue dissociation kit) containing papain with
subsequent mechanical digestion with gentleMACS™
Dissociator (Miltenyi Biotec, Madrid, Spain) according
to the manufacturer’s instructions. Cell suspensions were
filtered on 40-μm nylon mesh strainers and centrifuged
at 300 g for 10 min at room temperature. Pellets were
resuspended on 200 μl of 5% BSA in PBS with Fc Block
reagent (Miltenyi, Biotec, Madrid, Spain). Cell suspen-
sions were filtered on 40-μm nylon mesh strainers and
centrifuged at 300 g for 10 min at room temperature.
Pellets were resuspended on 200 μl of 5% BSA in PBS
with Fc Block reagent (Miltenyi). Cell suspensions were
co-labeled with antibodies for neural stem cell marker
PE anti-Prominin1/CD133 (Miltenyi Biotec, Madrid,
Spain), primitive neural stem cell marker PerCP-Cy 5.5
anti-Nestin (BD Pharmingen, San Jose, CA, USA), a as-
trocytes like-stem cell marker rat anti-GFAP (Invitrogen;
with donkey anti-rat Alexa Fluor 647, Jackson Immunor-
esearch) and two markers for proliferative progenitors,
FITC-labeled epidermal growth factor receptor (FITC
anti-EGFR; Invitrogen, Life Tech, Madrid, Spain), and
mouse anti-Mash1 (BD Pharmingen, San Jose, CA, USA;
and goat anti-mouse Alexa Fluor 647, Jackson Immunor-
esearch). For labeling the cytoplasmic protein nestin,
GFAP and Mash1, suspensions were mixed with
permeabilization solution (BD Cytofix/Cytoperm Kit, BD
Biosciences, Madrid, Spain) for 20 min at 4°C and
stained overnight.
In the case of cortex, cells were dissociated in a single cell
suspension using a gentleMACS™ Dissociator (Miltenyi)
according to manufacturer’s instructions. Cell suspension
was filtered on 50-μm nylon mesh strainers (BD Biosci-
ences) and centrifuged at 300 g for 10 min. Pellets were re-
suspended in 3 mL of 50% Percoll and overlaid on the top
of a gradient containing 3 mL of 30% of Percoll. The gradi-
ent was centrifuged at 500 g for 20 min at room
temperature. Cells were collected from the 30% to 50%
interface and resuspended on 200 μl of 2.5% BSA in PBS
with Fc Block reagent (Miltenyi). Cell suspensions were
incubated with conjugated antibodies CD11b-PerCP,
CD45-PE (Miltenyi, Biotec, Madrid, Spain), and Ly-6G-
APC (Biolegend, San Diego, CA, USA). After membrane
staining, cells were mixed with permeabilization solution
(BD Cytofix/Cytoperm Kit, BD Biosciences, Madrid,
Spain) for 20 min at 4°C and stained overnight to proceed
to the staining of intracellular Ym1 (1:100; StemCell Tech-
nologies Inc., Vancouver, British Columbia, Canada) and
CCR2 (Abcam) followed by incubation with immuno-
fluorescent anti-rabbit-Alexa 488 and anti-goat Alexa 647
(Life technologies, Madrid, Spain).Stained cells from cortex and SVZ were washed and
resuspended in 300 μl of FACS Flow (BD Pharmingen,
San Jose, CA, USA), and the whole suspension was ac-
quired using a FACSCalibur flow cytometer with Cell-
Quest software (BD Pharmingen, San Jose, CA, USA).
Isotype controls (Miltenyi, Biotec, Madrid, Spain) were
used in parallel.Blood cells characterization by flow cytometry
Peripheral blood cells were incubated for 10 min with a
standard ammonium chloride lysing solution. Samples
were washed twice with phosphate-albumin buffer (PAB;
0.0455% sodium azide and 0.1% bovine serum albumin)
and resuspended in PAB and mouse Fc Block (1:500; BD
Pharmingen, San Jose, CA, USA). Of cell suspension, 200
μl was incubated with conjugated antibodies CD11b-FITC
clone M1/70 and Ly6C-PE (Miltenyi Biotec, Madrid,
Spain) and Gr1-APC (RD system, Minneapolis, MN,
USA). The stained cells were washed and resuspended in
300 μl of FACS Flow (BD Pharmingen, San Jose, CA,
USA). All the events were acquired using a FACSCalibur
flow cytometer with CellQuest software (BD Pharmingen,
San Jose, CA, USA). Granulocytes were identified by for-
ward and side scatter analysis and confirmed by their ex-
pression of CD11b and Gr1.Statistical analysis
Data were expressed as mean ± SD. Comparisons be-
tween groups were performed using unpaired Student’s
t-test or one-way ANOVA with the Student-Newman
Keuls post hoc test for multiple comparisons. Compari-
sons of semiquantitative scores were analyzed with non-
parametric Mann-Whitney U-test. Linear association
between two variables was determined by the Pearson
correlation coefficient. Differences were considered sig-
nificant at P < 0.05.Results
Effect of aging on infarct size
First, permanent MCAO was performed on young and
aged C57BL/10 J mice either by distal or proximal occlu-
sion of the MCA, and the size of the infarct lesion was de-
termined 2 and 7 days later. Infarct volume at 2 days was
not affected by aging in both types of MCAO studied
(proximal and distal; Figure 1A, B). However, whereas the
size of the lesion equally regressed after proximal occlu-
sion in both young and aged animals at day 7 (Figure 1A),
this effect was not observed in the group of aged animals
with distal occlusion (Figure 1B; P < 0.05). Therefore, we
decided to use the groups with distal occlusion for subse-
quent studies.
Figure 1 Effect of aging on infarct development. Infarct size was determined by MRI (2 days) and Nissl (7 days) after MCAO in young (2 to 3
months) and aged (13 to 14 months) mice after proximal (A) and distal (B) occlusions (see Methods). Data are mean ± SD, n = 8, *P < 0.05.
MCAO, middle cerebral artery occlusion.
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As expected, ischemia induced microglial proliferation
in the ipsilesional cortex when compared with the sham
group, as demonstrated by an increased number in both
BrdU+ (Figure 2A) and BrdU+/Iba1+ (Figure 2B) cells in
the peri-infarct area. Importantly, brains of aged animals
had a higher number of BrdU+ cells and BrdU/Iba1+
cells in the ischemic boundary when compared with the
young mice 7 days after MCAO (40% BrdU+ and 60%
BrdU+/Iba1+ P < 0.05 aged vs. young; Figure 2A-C).
Effect of aging on cell infiltration
The number of infiltrated neutrophils was higher in aged
than in young mice analyzed by flow cytometry 1 day after
stroke (Figure 3A). We did not find any differences on
monocyte infiltration in both groups studied (Figure 3B).
Therefore, we studied M1/M2 infiltrated monocytes and
N1/N2 infiltrated neutrophils populations 1 day after
stroke, demonstrating that aged animals not only had a
higher number of infiltrated M1 monocytes (Cd11b+,
CD45hi, CCR2+, Ym1− cells, Figure 3B and plot) but also
of N1 neutrophils (Cd11b+, Ly6Ghi, CD45hi, Ym1− cells,Figure 2 Effect of aging on microglial proliferation and cell infiltration. Num
(cortex) at 7 and 14 days after MCAO in young and aged mice. The numbe
quantified on digitalized confocal images (see Methods). Representative im
and aged mice. Scale bar = 50 μm (C). MCAO, middle cerebral artery occluFigure 3A and plot) than young animals (P < 0.05 young
vs. aged; Figure 3A, B).
Finally, we also explored the different populations of
circulating leukocytes (neutrophils and monocytes) by
flow cytometry, but we did not detect any differences be-
tween young and aged mice (data not shown).Effect of aging on SVZ cell proliferation
In order to ascertain the effect of aging on SVZ cell pro-
liferation, we first studied the number of BrdU+ cells in
this area 7 and 14 days after MCAO, after a pulse of
BrdU at days 5 to 6. Exposure to distal MCAO did not
significantly affect the number of BrdU+ cells in the
SVZ, either in young or in aged mice, when studied 7
days after MCAO. However, in aged animals, MCAO
caused an increase of the BrdU+ cells in the SVZ at 14
days after injury (Figure 4A, P < 0.05). In addition, aged
sham-operated animals showed a lower number of pro-
liferative cells in the SVZ at 7 days (BrdU+ cells; Figure 4A,
P < 0.05), as previously reported for physiological neuro-
genesis [14].ber of BrdU+ (A) and BrdU+/Iba1+ (B) cells in the peri-infarct area
r of BrdU+ and BrdU+/Iba1+ cells (microglial/macrophages cells) was
ages of Iba1+ cells in the ipsilesional peri-infarct hemispheres in young
sion.
Figure 3 Effect of aging on cell infiltration. Flow cytometric analysis of brain neutrophils and monocytes in sham or ischemic mice brain 1 and 2
days after ischemia in young and aged mice (A, B). Upper: quantification of total neutrophils and monocytes. Right Lower: quantification of N1
(Ym1−) and N2 (Ym1+) neutrophils (Cd11b+, Ly6Ghi, CD45hi). Left Lower: quantification of M1 (Ym1−) and M2 (Ym1+) monocytes (Cd11b+, CD45hi,
CCR2+). Data are mean ± SD, n = 6 to 8 in each group. P < 0.05.
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tion depends on infarct size after stroke in young mice [8],
we decided to study whether this effect is also observed in
aged mice, by including an additional group of mice in
which MCAO was performed proximally in order to ob-
tain different lesion volumes. As expected, the groups with
the proximal occlusion had significantly larger infarct vol-
umes than the distal occlusion groups (Figure 1A). How-
ever, when we studied SVZ cell proliferation (BrdU+ cells)
at day 7 after stroke in the groups of aged animals (prox-
imal and distal occlusion), we did not find any correlation
between infarct size and cell proliferation determined
at the ipsilateral SVZ 7 days after injury (Figure 4B;
r = -0.100, n = 10, P > 0.05) in contrast with the positive
correlation found in young mice [8].In order to confirm the effect of aging on SVZ prolif-
eration and to establish the nature of the cells affected
in the SVZ, we characterized by flow cytometry the dif-
ferent cell types present in this area at earlier times, 1
and 2 days after distal MCAO, in young and aged mice.
Our results show the presence of two major cell popula-
tions, as we have previously reported [8]: a population
of prominin-1+/EGFR+/nestin+ cells in which approxi-
mately 90% are GFAP+ cells, corresponding to the pri-
mary neural stem cells (astrocyte-like type-B cells) and a
second population of prominin-1+/EGFR+/nestin− cells,
consistent with the transit-amplifying cells (type-C cells),
in which about 50% are Mash1+ (Figure 4F), correspond-
ing to the type C. Importantly, we found that aged mice
showed a smaller number of type-B cells in sham animals
Figure 4 Effect of aging on SVZ cell proliferation. (A) Number of BrdU+ cells in the SVZ at 7 and 14 days after MCAO in young and aged mice.
Data are mean ± SD, n = 6 to 8. (B) Correlation between number of BrdU+ cells in SVZ at 7 days and infarct size from aged mice (n = 10). (C)
Diagram with SVZ cell markers. (D) Scheme. (E) Cytometric quantification of prominin-1+/EGFR+/nestin+ cell population (right upper) and of type-B
cells (GFAP+ cells; right lower). (F) Quantification of prominin-1+/EGFR+/nestin− cell population (left upper) and of type-C cells (Mash1+ cells; left lower).
SVZ cells were obtained after MCAO from young and aged mice. Cell suspensions were labeled with antibodies for the different markers and analyzed
by flow cytometry (see Methods for details). Data are mean ± SD, n = 6 to 8, *P < 0.05. MCAO, middle cerebral artery occlusion; EGFR, epidermal
growth factor receptor; GFAP, glial fibrillary acidic protein; SVZ, subventricular zone.
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aged MCAO; P < 0.05), suggesting a global inhibitory role
of aging in the proliferation of type-B cells.
In contrast, in the prominin-1+/EGFR+/nestin− cell
subset (type-C cells), we have found a specific and
marked increase of Mash1+ cells only after MCAO and
in young but not in aged mice (Figure 4F; young MCAO
vs. aged MCAO; P < 0.05). Therefore, aging inhibits pro-
liferation of type-B and C cells after stroke.
Finally, in order to discard that the decreased cell num-
ber found in the group of aged animals was not due to in-
creased apoptosis [6], we determined apoptosis (caspase-3
positive cells) in both the SVZ and in the cortex from
young and aged animals. We did not find any differencesbetween both groups of animals at both tissues and time-
points (7 and 14 days after stroke) studied (data not
shown).
Effect of aging on neuroblast migration toward the
injured area
We next explored the effect of aging on the neuroblast
population (type-A cells) in 3 migratory zones ranging
from the SVZ (Z1) through the corpus callosum (Z2) to-
ward the damaged area (Z3), 7 and 14 days after the ische-
mic insult. We did not find any difference in the density
of neuroblasts (DCX+ cells) when young-adult and aged
mice were compared 7 days after MCAO (Figure 5C). Im-
portantly, 14 days after MCAO, the density of DCX+ cells
Figure 5 Effect of aging on neuroblast migration. (A) Scheme, (B) representative images, and (C, D) number of neuroblasts (doublecortin+ DCX+
cells) in three migratory zones (Z1, Z2, Z3) at 7 and 14 days after MCAO in young and aged mice. Migratory zones were established from the SVZ
(Z1) through the corpus callosum (Z2) toward the damaged area (Z3) (see Methods). Data are mean ± SD, n = 6 to 8, *P < 0.05. Scale bar = 200 μm.
MCAO, middle cerebral artery occlusion.
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(Figure 5B, D; P < 0.05). When each group was analyzed
separately, we found that DCX+ cells in Z2 and Z3 de-
creased from 7 to 14 days in the young but not in the aged
group, suggesting impairment in migration caused by
aging.
Effect of aging on the number of new neurons in the
peri-infarct cortex
Finally, we studied the number of mature differentiated
interneurons (BrdU+/NeuN+/GAD67+ cells) in the ipsile-
sional cortex 14 days after the ischemic insult. Interestingly,
we found that the number of BrdU+/NeuN+/GAD67+ cells
in the peri-infarct cortex was significantly lower in aged
than in young mice 14 days after MCAO (Figure 6A, B;
young MCAO vs. aged MCAO, P < 0.05). No new neurons
(BrdU+/NeuN+) were found in the cortex of sham-operated
mice.Discussion
In this study, we have explored the role of aging on
neurogenesis after stroke by using a permanent model of
focal ischemia in young and aged mice. Our data show
that (i) aging increases microglial proliferation in the is-
chemic boundary and the number of M1 monocytes and
N1 neutrophils, whilst decreasing the alternative M2 and
N2 phenotypes; (ii) cell proliferation (number of BrdU+
cells) at the SVZ is dependent on infarct size after stroke
in young but not in aged animals; (iii) aging inhibits SVZ
cell proliferation, as shown by a decreased number of both
type-B cells (prominin-1+/EGFR+/nestin+/GFAP+ cells) in
both sham and ischemic brains and of type-C cells (pro-
minin-1+/EGFR+/nestin−/Mash1+ cells) at day 1 after
stroke but not in sham mice; (iv) aging inhibits migra-
tion of neuroblasts as shown by an accumulation of
neuroblasts (DCX+ cells) in Z2 and Z3 migratory zones
at 14 days after injury; and (v) consistently, aged mice
Figure 6 Effect of aging on the number of new neurons in the peri-infarct cortex. (A) Representative images and (B) number of adult interneurons
(BrdU+/NeuN+/GAD67+ cells) in the ipsilesional cortex at 14 days after MCAO in young and aged mice. Data are mean ± SD, n = 6-8, *P < 0.05. Scale
bar = 25 μm.
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(NeuN+/BrdU+/GAD67+ cells) in the cortical peri-
infarct area at 14 days after stroke. We have also found
that for small cortical infarcts (obtained by distal occlu-
sion), lesion does not regress in aged mice 7 days after
injury whilst it does in young animals.
Indeed, after a distal occlusion, the size of the lesion
does not regress in aged mice at 7 days after injury as it
does in young mice, showing larger infarcts at this time.
A possible justification to explain the regression in small
but not large infarcts could lie on the fact that small in-
farcts are more amenable to modulation by different
mechanisms such as those processes that underlie the
evolution of ischemic penumbra at shorter times, the re-
sponse of resident microglia and the degree of infiltra-
tion of peripheral cells. Indeed as we commented below,
both microglia proliferation and neutrophil infiltration
are increased in aged mice using this model, and both
could underlie the smaller regression found. Previous re-
ports showed that aged rodents develop larger infarct
volumes than young animals when determined at early
times poststroke [15]. However, we have found this dif-
ference at later times (7 days after injury) when they did
not find any significant effect. Factors such as the ische-
mic model used, degree of aging of the animals, species,
or strain of animals might explain this apparent contro-
versy [1,15,16].
Several issues have been described to obstruct the re-
covery of the lesion in aged animals, including the so-called ‘inflamm-aging’ state [2] found in aged animals.
Indeed, we have found that aged animals show a higher
proliferation of microglia in the ipsilateral cortex as
demonstrated by an increase in BrdU+ and BrdU+/Iba1+
cells 7 days after ischemia when compared with young
mice. Our results support the existence of an activated
basal state (inflamm-aging) and are in agreement with
previous reports describing that the number of BrdU+
cells (45% of them corresponding to reactive microglia)
in the infarcted hemisphere of aged rats at days 3 and 7
vastly exceed those of young rats [15,17]. Consistently, it
has been described that basal mRNA expression of
CD11b and Iba1, markers of activated microglia, is higher
in the aged than in the young brain after stroke [4].
Importantly, we have also found a higher number of infil-
trated neutrophils in aged animals, as previously demon-
strated [18]. In this context, our data also show that aging
enhances the number of M1 monocytes and N1 neutro-
phils, phenotypes associated to a pro-inflammatory state.
Our results are in agreement with those demonstrating
that aging enhances classical M1 activation, mitigating al-
ternative M2 activation [19]. The evidence in the literature
on N2 neutrophils is still scarce, as this phenotype was
only recently described [20]. N2 neutrophils, similarly to
M2 monocytes, have been implicated in neuroprotection
by increasing neutrophil clearance and resolving inflam-
mation [20].
We have also found that, in aged mice and under is-
chemic conditions, SVZ cell proliferation (BrdU+ cells) 7
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shown by the negative correlation found. We recently
published that in young animals there is a correlation be-
tween SVZ cell proliferation and infarct size [8]. The re-
duced neurogenesis under physiological conditions and
after stroke that we have found in aged animals might ex-
plain the lack of correlation found. In fact, our data in
sham-aged animals show that physiological neurogenesis
is reduced in the brains of aged rodents, with a decrease
in the number of BrdU+ cells (proliferating cells) and
type-B cells (prominin-1+/EGFR+/nestin+/GFAP+ cells), in
agreement with previous results (for review, see [5]). Inter-
estingly, we have found that, after stroke, aging not only
decreases the number of astrocyte-like type B (in both
sham and MCAO groups) but also of type-C cells (promi-
nin-1+/EGFR+/nestin−/Mash1+ cells) in the SVZ, in this
case, only after injury. Altogether, our results indicate that
aging affects neural progenitors, although the effect is dif-
ferent in each cell population either in control (sham) or
in ischemic conditions. We have also demonstrated that
the decreased proliferation found in the group of aged ani-
mals is not due to increased apoptosis as previously re-
ported [6], at least at the time studied. To our knowledge,
this is the first demonstration that after stroke, aging in-
hibits the proliferation of type-B and C cells in the SVZ.
Our results are in agreement with those from Jin et al.
showing that stroke-induced neurogenesis is preserved
but reduced in the aged rodent brain [21].
Furthermore, we have shown that aging delays or
blocks the neuroblast migration process from the SVZ
toward the damaged area. In our study, we examined the
neuroblast population (type-A cells; DCX+) in three mi-
gratory zones ranging from the SVZ (Z1) through the
corpus callosum (Z2) toward the damaged area (Z3), at
two different times, 7 and 14 days after the ischemic in-
sult. Two weeks after the infarct, we found that the
density of neuroblasts at the Z2 and Z3 zones, despite a
decreased proliferation at the SVZ, increased in aged
mice when compared with those from young animals,
suggesting that aging hampered the migration process
resulting in an accumulation of these cells. Several fac-
tors might be involved in the altered migration process
found in aged animals. Although we did not find any
correlation between microglia and neuroblast migration,
we cannot discard that the intense inflammatory reaction
(inflamm-aging) that we have found in aged mice might
contribute to a rapid formation of growth-inhibiting scar
tissue in the infarcted area that might impair migration as
reported [3,17]. In addition, it has been described that fac-
tors involved in the migration process such as EGF [22]
and VEGF [23] are downregulated or inhibited during
aging [24,25].
Finally, our data show that, in young animals, stroke
induces the appearance of new neurons close to thedamaged area, which are interneurons (GAD67+ cells).
Although the number found appears relatively low, it is
likely to be remarkably underestimated, as the figures re-
ported only represent the fraction of cells that reach the
infarct and differentiate into neurons among those that
proliferated at days 5 and 6 after the ischemic injury,
when the BrdU pulse was applied. Importantly, we have
found that aged mice show a substantially decreased
neurogenesis at the cortical area at 14 after stroke, in ac-
cordance with the suppression of the migratory process
found. Aging may therefore explain recent evidence
reporting that neurogenesis is negligible in the human
neocortex after ischemic stroke in aged patients (average
age of 70; [26].
Conclusions
In summary, we have confirmed that in aged mice,
stroke-induced neurogenesis is maintained but reduced.
Importantly, we are now demonstrating that aging af-
fects proliferation of specific populations of neural pro-
genitor cells, blocks migration of neuroblasts to the
damaged area, and decreases the number of new inter-
neurons in the cortical area. Therefore, the search for
the mechanisms that underlie this process might have
important therapeutic implications in old patients with
stroke in order to increase the different processes of
neurogenesis. Furthermore, our results showing different
effects depending on age of animals, strongly remark the
importance of using aged animals for the study of
stroke.
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